Document:

Document

Exhibit 10(c)

BECTON, DICKINSON AND COMPANY
PERFORMANCE INCENTIVE PLAN
AMENDED AND RESTATED EFFECTIVE AS OF AUGUST 30, 2022

PURPOSE

    The purpose of the Performance Incentive Plan (the “Plan”) is to provide annual incentive payments to associates for their contribution to the Company’s successful financial performance and the accomplishment of strategic objectives.

Notwithstanding anything in this plan to the contrary, the payment of annual incentives, if any, is solely within the discretion of the PIP Steering Committee and the Board of Directors, except that payment in excess of the plan guidelines will not be made. No employee has any vested right to any such payment. 

PIP STEERING COMMITTEE

    The PIP Steering Committee will be responsible for administering this Plan, except that the Compensation and Human Capital Committee of the Board of Directors (the "Compensation Committee") will be responsible for administering this Plan with respect to the Chief Executive Officer of the Company and other members of the Executive Leadership Team (the "ExLT") and for selection and approval of total Company metrics, targets, and payouts, as specified herein.  The PIP Steering Committee will consist of no less than three persons, including the Chief Executive Officer, Chief Financial Officer, and Chief People Officer and such other senior executives as are designated from time to time by the Chief Executive Officer. The Chief People Officer shall have authority to act on behalf of the PIP Steering Committee with respect to all matters under this Plan.

ELIGIBILITY

    Participation in any particular fiscal year is generally restricted to employees of the Company and its worldwide subsidiaries in Job Group 4 and above positions (other than those covered under other incentive plans or sales incentive plans) and other key positions as may be approved by the PIP Steering Committee.  Current employees promoted to, and persons newly hired to, eligible positions during a particular fiscal year may be considered for a pro-rata bonus; provided that such employees are promoted to, or newly hired to, eligible positions on or before July 1 of the particular fiscal year.  Persons employed by companies acquired by the Company which have pre-existing incentive, profit sharing or similar programs will not participate in this Plan until and unless those plans are superseded by this Plan. For the avoidance of doubt, employees who transferred out of the Company due to a divestiture of a subsidiary or business unit during the fiscal year will not be eligible for an incentive payment under this Plan with respect to the fiscal year in which the spin-off occurs, except as otherwise determined by the Compensation Committee. 

PARTICIPATION LEVELS

    Plan targets for eligible employees are determined based upon the scope and responsibilities of the position. Plan targets for eligible employees who have received a 

promotion or other role change during the applicable year will be pro-rated based on the eligible employee’s time in each role.   

DETERMINATION OF PERFORMANCE CRITERIA

    Prior to or shortly following the beginning of a fiscal year, the Compensation Committee shall establish financial and strategic criteria, targets and related formula(s) with respect to the total Company, which shall apply to the ExLT and other applicable associates, and the PIP Steering Committee shall establish financial and strategic criteria, targets and related formula(s) tied to results below total Company, including targets related to segment, business unit, region, and/or country performance.

INCENTIVE CALCULATION

Incentive payments shall be made under the Plan based upon total Company, segment, business unit, region, and/or country performance, as applicable, as measured against the financial and strategic criteria and targets established as set forth above. Subject to the terms of this Plan as set forth herein, Incentive Payments for individual participants shall generally be equal to the applicable final business modifier (i.e. the percentage of achievement of the financial and strategic criteria and targets upon application of the applicable pre-approved formula) multiplied by the participant's target and salary or earnings, as applicable. For participants approved for Exceptional Impact (discussed below), this calculation is also increased by a set Exceptional Impact Reward Percentage to determine each recipient’s Incentive Payment.  For participants who have been designated as needing performance remediation, this calculation will be reduced by a set percentage. For the ExLT, the Compensation Committee (and in the case of the Chief Executive Officer, the independent directors of the Board) shall approve the final incentive payment amount in its sole discretion after considering the formula noted above. For the avoidance of doubt, the final incentive payment for any ExLT member, as determined by the Compensation Committee or the Board, as applicable, may greater or less than the amount determined pursuant to the formula noted above. 

DETERMINATION OF FUNDING LEVELS

    Funding levels relating to ExLT incentive payments shall be determined by the Compensation Committee based on total Company performance as measured against the corporate financial and strategic performance targets in accordance with the formula established by the Compensation Committee. Funding levels tied to incentive payments below total Company shall be determined by the PIP Steering Committee based on the satisfaction of the performance targets in accordance with the formula established by the PIP Steering Committee at the beginning of the Fiscal Year. These funding levels are adjusted both upwards (for performance above target) and downwards (for performance below target).  With respect to total Company, the Compensation Committee has the discretion to make adjustments to the Company’s operating results for unbudgeted items that are not considered part of BD’s ordinary operations and other events that significantly impacted BD’s performance. Similarly, the PIP Steering Committee has this same discretion for results below total Company. 

DETERMINATION OF INCENTIVE POOLS AND FINAL INCENTIVES

    (a)    Theoretical Incentive and Exceptional Impact Pool

    Following the close of each fiscal year, a hypothetical incentive pool will be established assuming achievement at 100% of target for participants, and the PIP Steering Committee will 
2

hold back an amount of the hypothetical incentive pool, in an amount determined by the PIP Steering Committee in its sole discretion, to be established as an Exceptional Impact Pool.  For purposes of determining the hypothetical incentive pool, the target for participants who have had a salary, individual target, or status change during the applicable fiscal year will be pro-rated based on the period during the year that the original salary, individual target, or status and the adjusted salary, individual target, or status was applicable.  
    
(b)    Final Business Modifiers 

    Following the close of each fiscal year, the Compensation Committee (with respect to incentives based on total Company performance) and the PIP Steering Committee (with respect to incentives based on segment, business unit, region and/or country performance) will determine the final achievement level of the financial and strategic performance targets and will apply the formula established by the Compensation Committee or PIP Steering Committee, as applicable, to determine the final business modifiers for the applicable fiscal year.  

    (c)    Communication

    The operating unit and performance results will be communicated throughout the organization to the extent that the Company deems appropriate and subject to any confidentiality concerns.

    (d)    Incentive Payment Recommendations

The ExLT will review and approve the list of designated participants below the ExLT who have had exceptional impact during the fiscal year for an additional amount to be paid through the Exceptional Impact Pool. The Compensation Committee will review and approve any ExLT participants who are considered to have had exceptional impact during the fiscal year and who will be eligible for an additional amount to be paid through the Exceptional Impact Pool, and will determine, for such ExLT participants, the Exceptional Impact Reward Percentage that will apply to such ExLT participants. ExLT members who have been designated as needing performance remediation will receive a reduced incentive amount, as determined by the Compensation Committee in its sole discretion. For all participants below the ExLT, the PIP Steering Committee determines the Exceptional Impact Percentange. 

    The PIP Steering Committee will apply the final business modifiers, and Exceptional Impact Reward Percentage to the individual incentive targets as applicable to determine the final incentive amounts for participants (other than the ExLT). Participants who have been designated as needing performance remediation will receive a reduced incentive amount.  The Compensation Committee will approve the final total Company business modifier and will determine the final incentive payments for the ExLT (inclusive of Exceptional Impact awards)  in its sole discretion. 

Participants who have been on an approved leave of absence during the fiscal year may have their incentive amounts pro-rated based on Company policy in the applicable region or country. No individual may receive an incentive payment in excess of 200% of the their target incentive. 

FINAL REVIEW AND APPROVAL

    All incentive payments for the participants other than the ExLT will be reviewed and approved by the Chief Executive Officer, in the aggregate or on a case-by-case basis, as appropriate.  In the case of the ExLT, recommendations will be subject to final review and 
3

approval by the Compensation Committee(and in the case of the Chief Executive Officer, the independent directors of the Board). The Compensation Committee (and the Board, as applicable) has the discretion to reduce payouts based on any factors it deems appropriate, including whether an individual has taken unnecessary or excessive risk.  
    
    (a)    Payment

    Incentives will generally be paid by January of the calendar year following the year in which they are awarded (unless deferred by the participant). Except in cases of death, disability, retirement, or involuntary terminations due to the elimination of employees’ position, no incentive payments will be made to individuals who are not active employees on the final day of the fiscal year.  Employees who are terminated for cause prior to the distribution date will forfeit their incentives.

    If an employee is terminated by reason of death, disability, or retirement, his or her incentive payment will paid in or around January of the calendar year following the year in which it was awarded and will be based on applicable business performance and pro-rated based on the number of days the employee was actively at work during the fiscal year in which the incentive payment was awarded.

    Incentives awarded to any employee who dies prior to the distribution date may be made to the employee's estate or beneficiares at the discretion of management.

If a U.S.-based employee has experienced a Termination Due to Workforce Restructuring, as determined in accordance with the U.S. BD Severance Plan, or an employee who is not a U.S.-based employee is terminated by reason of an involuntary termination due to the elimination of the employee’s position, as determined in the sole discretion of the applicable Human Resources business partner, such employee may receive a pro-rated incentive payment at the target level of performance based on his or her individual incentive target and salary or earnings as applicable.   In the event that an employee shall receive a pro-rated incentive payment under this paragraph, the incentive payment will be pro-rated based on the number of days the employee was actively at work during the fiscal year in which the incentive payment was awarded and be paid in accordance with the following:

(i)  if the employee is a U.S.-based employee, the pro-rated incentive payment shall be paid under, in accordance with, and subject to, the terms of the U.S. BD Severance Plan and subject to the Plan Administrator of the U.S. BD Severance Plan’s discretion to eliminate or modify such pro-rated incentive payment; and

(ii)  if the employee is not a U.S.-based employee, the pro-rated incentive payment shall be paid under the Plan in accordance with applicable law, subject to local rules, practices, procedures, and limitations that would provide for a lesser benefit (e.g., probationary periods); provided that the lead Human Resources business partner and the Regional Total Rewards Director may, in their sole and absolute discretion, authorize a pro-rated incentive payment that is different from the amount otherwise set forth in this Plan or determine that an individual is not entitled to a pro-rated incentive payment; and, provided further that the payment of any incentive under this subsection shall also be in satisfaction of any local severance plan, arrangement, or law that requires the payment of bonus (or any similar compensation) as part of severance or separation pay. 

Notwithstanding the foregoing, participants in the ExLT, including the Chief Executive Officer, are eligible to receive a pro-rated bonus pursuant to this Plan unless they are a participant in or a party to a separate plan, agreement, or arrangement that was approved by the Company.
4

    (b)    Exceptions

    Any recommendations for exceptions to the provisions of the Plan must be submitted to the PIP Steering Committee for review and are subject to final approval by the Chief Executive Officer.  Any exceptions applicable to the ExLT are further subject to approval by the Compensation Committee (and in the case of the Chief Executive Officer, the independent directors of the Board).

RECOVERY OF INCENTIVE PAYMENTS

Any incentive payment approved under this Plan shall be subject to the terms of the Company’s Policy Regarding the Recovery of Compensation, , as the same may be subsequently amended (the “Policy”); provided, that no amendment to the Policy shall adversely affect the rights of an employee with respect to any incentive payment that is approved in accordance with this Plan prior to such amendment.

5Document

Exhibit 10(p)
ADVISORY BOARD CONSULTING AGREEMENT
This Advisory Board Consulting Agreement (“Agreement”) is made and entered into on October 31, 2022 (“Effective Date”), by and between Becton, Dickinson and Company, a New Jersey corporation with an address at One Becton Drive, Franklin Lakes, NJ 07417 (“BD”), and Claire M. Fraser, with an address of [***] (“Consultant”) (each of BD and Consultant being a “party” and collectively, the “parties”).
WHEREAS, BD has formed a Scientific Advisory Board (the “SAB”) to advise BD on matters relating to new and potentially disruptive technologies, trends and breakthrough innovation, guidance on changes in healthcare practice and delivery, identification and sourcing of new technologies that align with BD’s growth strategy, supporting BD’s culture of innovation and evaluating and advising on BD’s innovation portfolio and roadmap to drive innovation investment and revenue growth and related matters (collectively, the “Field”); and
WHEREAS, BD wishes to have the benefit of the Consultant’s knowledge and experience by having Consultant serve, and Consultant wishes to serve, on the SAB in accordance with the terms and conditions set forth herein; 
NOW THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties agree as follows:
1.SERVICES TO BE PERFORMED
1.1BD hereby agrees to retain the Consultant as a consultant, and the Consultant shall serve the Company as a consultant and a member of the SAB, upon the terms and conditions set forth herein.  As a member of the SAB, Consultant shall provide BD her advice and perspective relating to the Field and shall serve as co-chair of the SAB (the “Services”).  It is understood that as a member of the SAB, members of the SAB, including the Consultant, have no decision-making or voting authority with respect to any matters considered by the SAB, and that any recommendations made by the SAB or the Consultant are subject to the review, consideration and final approval of BD management or the BD board of directors, as appropriate. 
1.2It is expected that the SAB will meet on a quarterly basis and Consultant shall use her reasonable efforts to participate in each SAB meeting, either in person or by means of remote communication.  Consultant shall also make herself available to consult with BD outside of SAB meetings as reasonably requested by BD.  Consultant’s point of contact at BD shall be Elizabeth McCombs. 
1.3Notwithstanding anything else in this Agreement to the contrary, the parties agree that the Consultant shall not be required to provide more than eight (8) hours of Services per week, or provide more than twenty-five (25) hours of Services per month.
1.4Consultant represents and warrants that Consultant is under no obligation to any third party that would interfere with Consultant rendering to BD the Services as herein defined or which would be inconsistent with any of Consultant’s representations or obligations under this Agreement.
1.5Consultant represents and warrants that Consultant has not been ineligible and is not currently excluded, debarred, or otherwise ineligible to participate or under investigation related to federal health care programs as defined in 42 U.S.C. § 1320a-7b(f) (“Federal Health Care Programs”) or generally from federal procurement and non-procurement programs, and does not appear on any list of prohibited persons maintained by the United States or other applicable government or Government Authority (“Prohibited Lists”), including the list of 
1

“Specially Designated Nationals and Other Blocked Persons” maintained by the U.S. Department of Treasury, and the “Denied Persons List” maintained by the U.S. Bureau of Industry & Security.  
2.PAYMENT FOR SERVICES
2.1In consideration for Consultant providing the Services described above in accordance with the terms of this Agreement, BD shall pay Consultant a fee (the “Consulting Fee”) at a rate of nine thousand five hundred dollars ($9,500) per year, payable in quarterly installments, with the first installment being paid on or about October 31, 2022. 
2.2BD shall reimburse Consultant for Consultant’s reasonable travel, lodging, meal and other out-of-pocket expenses incurred in connection with her performance of the Services.  Consultant shall provide BD with appropriate invoices or other evidence of such expenses.
2.3Consultant acknowledges and agrees that the compensation payable hereunder represents BD’s full and complete obligation for any and all Services to be rendered by Consultant under this Agreement.  
3,    TERM
3.1    Subject to the terms and conditions hereof, the term of the Consultant’s consulting arrangement and service on the SAB shall commence on the Effective Date and shall continue through September 30, 2023, subject to earlier termination as provided herein. This Agreement may be renewed by mutual consent of both parties. 
3.2    Either party may terminate this Agreement with or without cause prior to its termination date upon notice to the other party.  In the event of an early termination of this Agreement, the Consultant shall be entitled to payment for services performed prior to the effective date of termination.  
3.3    Sections 4, 5, 6 and 7 of this Agreement shall survive any termination of this Agreement. 
4CONFIDENTIAL INFORMATION
4.1    “Confidential Information” shall mean and include, any confidential and proprietary information relating to BD, including without limitation, the business, technology, products, processes of BD or its vendors or customers.
4.2    Confidential Information may be written, documentary, recorded, or otherwise fixed in a tangible medium, electronically, orally or visually, and includes Confidential Information disclosed by BD to Consultant or acquired by Consultant directly or indirectly from BD.
4.3    Consultant agrees to maintain the Confidential Information in strict secrecy and confidence, to not disclose Confidential Information to a third party other than other members of the SAB, and to use Confidential Information only for purpose of providing the Services.  
4,4    The obligations of Consultant set forth in Section 3 shall not apply to any information that:
(a)    was known by Consultant at or prior to the Effective Date, except to the extent unlawfully appropriated by Consultant, such prior knowledge being evidenced by contemporaneous written evidence of same; or
(b)    is or becomes generally known in the trade or business pertaining to such information or otherwise becomes publicly known at or after the time of disclosure by BD, through no wrongful act of Consultant; 

(c)    is received by Consultant from a third party, prior to the Effective Date and without restriction; or
(d)    is developed by Consultant independent of any Confidential Information, as evidenced by contemporaneous written evidence of the same.
4.5    Confidential Information may be disclosed, without breaching this Agreement, to the extent such Confidential Information is required to be disclosed by a court or judicial or governmental authority of competent jurisdiction, or by any applicable law, rule or regulation, and in such event, only after Consultant provides prompt written notice to BD so as to enable BD to resist any such required disclosure and/or to obtain suitable protection regarding such required disclosure.
4.6    All Confidential Information disclosed by BD shall be deemed and shall remain the sole and exclusive property of BD.  All tangible Confidential Information, including all copies and samples, shall promptly be destroyed or returned to BD upon written request from BD.  
4.7    Other than information relating to the Services provided by Consultant to BD, which shall be deemed BD Confidential Information, BD personnel are not authorized to receive Consultant’s information in confidence.  All other communications from Consultant to BD, except for BD Confidential Information, are considered to be made on a non-confidential basis.
4.9    Nothing contained herein shall be construed, either expressly or implicitly, to grant to Consultant any right or license under any patent, copyright, trademark, trade secret or other proprietary right now or hereinafter owned or controlled by BD.
5.    DISCLOSURE AND ASSIGNMENT OF INTELLECTUAL PROPERTY
5.1    All patentable and unpatentable inventions, discoveries, improvements, design rights, works of authorship, copyrights, trade secrets, know-how and any equivalents thereof (“Intellectual Property”) conceived, made, or developed by Consultant during or in connection with activities under this Agreement, or which arise out of Confidential Information of BD provided to and/or otherwise acquired by Consultant pursuant to this Agreement, shall be the sole and exclusive property of BD without further compensation to Consultant.  In addition, Consultant shall execute and deliver to BD all descriptions, applications, assignments and other documents and instruments necessary or proper to carry out the provisions of this Agreement, without further compensation, and Consultant shall cooperate with and assist BD or its nominees in all reasonable ways and at all reasonable times to aid BD in obtaining, maintaining, defending and enforcing all Intellectual Property in the United States and elsewhere.  Such Intellectual Property shall be deemed Confidential Information for purposes of this Agreement.  
5.2    Consultant shall and does hereby irrevocably grant and assign to BD the entire assignable right, title and interest, without further compensation, in and to any and all of the Intellectual Property referred to in Section 5.1 above, together with: (a) the right to apply for patents and/or copyright registrations thereon in any and all countries of the world; and (b) the entire right, title and interest in and to any and all applications for patents and copyright registrations which may be prepared or filed thereon at BD’s discretion and expense, and in and to any and all of the eventuating patents and copyright registrations.
5.3    Nothing contained herein shall be construed to grant to Consultant any rights to BD technology or any license under any BD patent, copyright or trademark now or hereinafter in existence except for the limited purposes set forth herein.  BD shall be free to use all information that Consultant conveys or otherwise discloses to it without any further obligation to Consultant.
6.    INDEMNIFICATION

6.1    BD agrees to indemnify, defend and hold harmless Consultant from any and all damages, liabilities or expenses (including without limitation, attorneys' fees and any expenses incurred in establishing a right to indemnification hereunder) that the Consultant may incur arising from any claim, action, suit or proceeding relating to the performance of the Services under this Agreement, except to the extent they result from the bad faith of the Consultant.
7.    RELATIONSHIP OF PARTIES
7.1    This Agreement does not create an employer-employee relationship between BD and Consultant.  Consultant shall not hold himself out as an agent or representative of BD.  Consultant agrees that all services herein shall be rendered as an independent contractor, and Consultant shall have no authority to negotiate or execute agreements on behalf of BD or otherwise bind or obligate BD in any manner.  In addition, Consultant shall not be eligible to participate in any employee benefit program of BD.  Nothing contained in this Agreement is intended to create, or shall be construed as creating, any type of fiduciary relationship between Consultant and BD, except that Consultant shall be bound by the confidentiality obligations set forth herein.
8.    MISCELLANEOUS
8.1    All notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail to the address set forth above or sent by electronic mail to the address provided by the other party.
8,2    This Agreement may not be assigned by Consultant without the written consent of BD.
8.3    Consultant agrees and understands that in order to comply with applicable law or BD policies and processes, BD may disclose the existence of this Agreement and any payments made hereunder.
8.4    This Agreement shall be binding upon and inure to the benefit of the successors and assigns of BD and shall be binding upon and inure to the benefit of the successors and assigns of Consultant. 
8.5    The failure or delay of either party to enforce at any time any provision of this Agreement shall not constitute a waiver of such party's right thereafter to enforce each and every provision of this Agreement.
8.6    This Agreement is to be governed by and construed in accordance with New Jersey law, without giving effect to the principles of conflict of laws.  
8.7    Singular terms shall be construed as plural, and vice versa, where the context requires, and the headings or titles of the Sections or Subsections of this Agreement are for convenience only and shall not be used as an aid in construction of any provision hereof.  
8.8    If any provision of this Agreement is declared void or unenforceable by a court of competent jurisdiction, such provision will be severed from this Agreement, and the balance of the Agreement will remain in full force and effect.
8.9    This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

[Signatures on following page]

IN WITNESS WHEREOF, the parties have executed this Agreement on the date first above written.

									
	CONSULTANT	BECTON, DICKINSON AND COMPANY
	By:
	/s/ Claire M. Fraser                   	By: /s/ Joseph M. Smith, MD, PhD    

	Name:  Claire M. Fraser                   
	Name: Joseph M. Smith, MD, PhD

			Title: Chief Scientific Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]